The aberrant constitutive endocytosis of activated EGFR mutants not only confers enhanced signalling activity, but also promotes their colocalisation and association with c-SRC, thereby amplifying signalling dysregulation and contributing to tumour progression [184]. This evidence concerns the gene EGFR and neoplasm.